ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Mar 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
April 2026
Latest News
NRC approves TerraPower construction permit
Today, the Nuclear Regulatory Commission announced that it has approved TerraPower’s construction permit application for Kemmerer Unit 1, the company’s first deployment of Natrium, its flagship sodium fast reactor.
This approval is a significant milestone on three fronts. For TerraPower, it represents another step forward in demonstrating its technology. For the Department of Energy, it reflects progress (despite delays) for the Advanced Reactor Demonstration Program (ARDP). For the NRC, it is the first approval granted to a commercial reactor in nearly a decade—and the first approval of a commercial non–light water reactor in more than 40 years.
E. Hohmann, S. Safai, Ch. Bula, R. Lüscher, C. Harm, S. Mayer, O. Morath, E. Pedroni, S. Zenklusen
Nuclear Technology | Volume 175 | Number 1 | July 2011 | Pages 77-80
Technical Paper | Special Issue on the 16th Biennial Topical Meeting of the Radiation Protection and Shielding Division / Radiation Protection | doi.org/10.13182/NT11-A12273
Articles are hosted by Taylor and Francis Online.
Proton therapy is a widely used method of cancer treatment. Undesired secondary particles such as neutrons accompany the irradiation. Depending on the measurement position, the expected main dose contribution due to undesired secondary particles arises from neutrons with energies >20 MeV. Conventionally used Andersson and Braun-type survey instruments may underestimate the ambient dose equivalent up to a factor of 2 due to their limited response for high-energy neutrons. Therefore, it is desirable to investigate the neutron stray field in conditions comparable to therapy treatment, in particular the resulting dose to equipment placed in the treatment vault to estimate possible consequences to its operation. The irradiation of a water phantom with 200-MeV protons adequately reproduces these conditions.